Article
The BBC Seems To Hate White People...
aboutLiberty Portal
Liberty Portal is your gateway for free markets and free thinking. We aggregate open-sourced content to promote and popularize important people and lessons within the liberty movement.
suggested
Oct 24, 2026 / Tyler Durden
Ultrawealthy Reshaping Country-Fried City With $35 Million Estates And Lamborghinis
Ultrawealthy Reshaping Country-Fried City With $35 Million Estates And Lamborghinis
America's wealthiest residents are increasingly abandoning traditional luxury enclaves in New York, Los Angeles and Chicago, fueling an extraordinary real estate boom in an unlikely corner of the South.
Nashville, Tennessee, once best known for country music and Southern hospitality, is rapidly transforming into a playground for multimillionaires, complete with sprawling estates, exotic supercars and exclusive private clubs.
Sales of Nashville-area properties ranking among America's most expensive 1% have tripled since 2017. The national threshold for that exclusive category reached approximately $3...
Read more
May 12, 2026 / Tyler Durden
Dismal, Tailing 10Y Auction Sees Lowest Foreign Demand Since Jan 2025 As Yields Soar
Dismal, Tailing 10Y Auction Sees Lowest Foreign Demand Since Jan 2025 As Yields Soar
With 30Y yields trading on the wrong side of 5% today, all eyes were on today's 10Y refunding auction to see if it would be ugly enough to push yields to 4.50% or higher. Here is what happened.
Just after 1pm, the Treasury announced that the high yield on today's sale of $42 billion in 10Y paper was 4.468%, the highest yield since Jan 2025, and a 0.4bps tail to the When Issued 4.464%, the 4th consecutive...
Read more
Apr 6, 2026 / Tyler Durden
Big Pharma Forced To Yank COVID Vaxx Study Due To Lack Of Participants
Big Pharma Forced To Yank COVID Vaxx Study Due To Lack Of Participants
Authored by Ben Sellers via Headline USA,
Two of the major pharmaceutical companies connected with the controversial COVID vaccines were forced to abandon a new research study after failing to garner enough participants.
Pfizer and German vax maker BioNTech had sought to research an updated version of the vaccine in adults ages 50 to 64, but were unable to generate the data needed due to the low enrollment in the trials, Reuters reported.
The study was needed in order to meet new guidelines imposed by the Food and Drug Administration that...
Read more




